Keith DiPetrillo is a Scientific Director at Bristol Myers Squibb, specializing in nonclinical safety and toxicology. An innovative and creative pharmacologist with a PhD from Dartmouth, he has a strong record of leading teams to advance drug compounds into clinical trials, particularly in oncology and cardiovascular diseases. People often describe him as skilled, knowledgeable, and pragmatic.
Outside of his scientific work, Keith is committed to supporting health-related causes. He actively participates in and raises funds for the American Heart Associations Heart Walk, demonstrating a personal investment in advancing cardiovascular research and community well-being.
He is the editor of a book titled "Cardiovascular Genomics: Methods and Protocols, " part of the Methods in Molecular Biology series.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.